• Thurs news: AbbVie Parkinson’s drug. Arch raises $3B biotech fund. Biogen dropping failed Sage tremor drug. AZ gets sought-after Tagrisso OK. Pfizer withdrawing sickle cell med. See more on our front page

Whats going on





































A new CEO was named , any good? any impact?

Nice guy. Talks a lot. Makes many Many MANY PPT slides. Never really known for moving the needle on broad business initiatives. Check background at Walsh, Cegedim, FCG and CSC. Again, a nice guy, but never walked in the shoes of the customer and leading by power point will not bring him to success at AHM either.
 








Nice guy. Talks a lot. Makes many Many MANY PPT slides. Never really known for moving the needle on broad business initiatives. Check background at Walsh, Cegedim, FCG and CSC. Again, a nice guy, but never walked in the shoes of the customer and leading by power point will not bring him to success at AHM either.

haha...amen brother...A-MEN.